370
Views
14
CrossRef citations to date
0
Altmetric
Supportive care and acute toxicities

Serum Creatinine Versus Plasma Methotrexate Levels to Predict Toxicities in Children Receiving High-dose Methotrexate

, MD, , , MD, , M.A., , MD, , PhD & , MD show all
Pages 576-584 | Received 22 Jul 2015, Accepted 24 Aug 2015, Published online: 11 Nov 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xiao Li, Zhongguo Sui, Fanbo Jing, Wen Xu, Xiangpeng Li, Qie Guo, Shuhong Sun & Xiaolin Bi. (2019) Identifying risk factors for high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia. Cancer Management and Research 11, pages 6265-6274.
Read now

Articles from other publishers (13)

Randal K. Buddington, Thomas Wong, Karyl K. Buddington, Torben S. Mikkelsen, Xueyuan Cao & Scott C. Howard. (2023) Early clinical indicators of acute kidney injury caused by administering high-dose methotrexate therapy to juvenile pigs. Frontiers in Nephrology 3.
Crossref
Jennifer Kendrick, Lisa Jacques, Björn Baadjes & Roxane Carr. (2022) Comparison of Sodium Bicarbonate and Lactated Ringers Hydration for High-dose Methotrexate Chemotherapy in Children. Journal of Pediatric Hematology/Oncology 44:8, pages 442-445.
Crossref
Ya-qing Shen, Zhu-jun Wang, Xiao-yan Wu, Kun Li, Zhong-jian Wang, Wen-fu Xu, Fen Zhou & Run-ming Jin. (2022) Dose-individualization Efficiently Maintains Sufficient Exposure to Methotrexate without Additional Toxicity in High-dose Methotrexate Regimens for Pediatric Acute Lymphoblastic Leukemia. Current Medical Science 42:4, pages 769-777.
Crossref
Sharada Mailankody, Venkatesan Sampath Kumar, Shah Alam Khan, Shripad D. Banavali & Jyoti Bajpai. (2021) Resource‐appropriate selection of osteosarcoma treatment protocols in low‐ and middle‐income countries. Pediatric Blood & Cancer 69:3.
Crossref
Özlem Terzi, Ali Aycicek, Ezgi Uysalol, Duygu Yildirgan, Fatma Sek & Cengiz Bayram. (2022) Utility of repeated drug level measurements after high dose methotrexate infusion for treatment planning in pediatric leukemia. Sanamed 17:3, pages 137-143.
Crossref
Himani Dhingra, Manas Kalra & Amita Mahajan. (2020) Safe administration of high‐dose methotrexate with minimal drug level monitoring: Experience from a center in north India. Pediatric Blood & Cancer 67:11.
Crossref
Manikandan Dhanushkodi. (2021) High-dose Methotrexate. Indian Journal of Medical and Paediatric Oncology 40:03, pages 424-426.
Crossref
Ryan J. Beechinor, Patrick A. Thompson, Michael F. Hwang, Ryan C. Vargo, Lisa R. Bomgaars, Jacqueline G. Gerhart, ZoAnn E. Dreyer & Daniel Gonzalez. (2019) The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children’s Oncology Group. Clinical Pharmacokinetics 58:7, pages 899-910.
Crossref
Hye Won Yoon, Yoon Sun Ree, Hyo Sook Song, Jae Song Kim & Eun Sun Son. (2019) Delayed Elimination After High-dose Methotrexate in Pediatric Patients with Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma. Korean Journal of Clinical Pharmacy 29:2, pages 101-108.
Crossref
Jagdish Prasad Meena, Aditya Kumar Gupta, Mansingh Parihar & Rachna Seth. (2021) Clinical profile and outcomes of Non-Hodgkin's lymphoma in children: A report from a tertiary care hospital from India. Indian Journal of Medical and Paediatric Oncology 40:01, pages 41-47.
Crossref
Alan Davidson & Scott C. Howard. (2018) Delivering modern anticancer therapies in low‐ and middle‐income settings: We can be evidence based. Pediatric Blood & Cancer 65:12.
Crossref
Kalthi Vaishnavi, Deepak Bansal, Amita Trehan, Richa Jain & Savita Verma Attri. (2018) Improving the safety of high‐dose methotrexate for children with hematologic cancers in settings without access to MTX levels using extended hydration and additional leucovorin. Pediatric Blood & Cancer 65:12.
Crossref
Prateek Tiwari, Prasanth Ganesan, Venkatraman Radhakrishnan, Rajamanickam Arivazhagan, Trivadi S. Ganesan, Manikandan Dhanushkodi, Sidharth Totadri & Tenali Gnana Sagar. (2018) Prospective evaluation of the toxicity profile, and predictors of toxicity of high dose methotrexate in patients of acute lymphoblastic leukemia/lymphoma. Pediatric Hematology Oncology Journal 3:1, pages 1-5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.